The cost of your medication can vary from $50-$200 for a 30-day supply. Generally, the cost for a 30-day supply of Nexium (esomeprazole magnesium) 20 mg/1.25 mL is $70-$150 per month, depending on the pharmacy and quantity purchased.

Nexium (esomeprazole) 20 mg oral tablets are usually the most cost-effective option for treating frequent heartburn (heartburn that occurs 14 to 30 days after taking the medication). Nexium may also be the most effective treatment option for acid reflux (heartburn that persists past a 14-day supply).

Nexium is also available as an extended-release tablet (AR-ES).

Important Safety Information for Nexium:

• Keep out of reach of children.
• Never share your medication with anyone.
• Store the medication at room temperature, away from heat, moisture, and direct light.
• Keep your Nexium dosage as directed and follow your healthcare provider’s instructions. Nexium may cause serious stomach bleeding if taken with other medications. Serious side effects and interactions with other medications should be reported to your healthcare provider immediately.
• Store in a cool, dry place, out of reach of children.

Nexium may interact with other medications your doctor or healthcare provider is taking for you, stopping you from taking them or changing your dosage of them could increase side effects. Tell your doctor or pharmacist if you are taking any other medications, including any prescription and nonprescription medication. This includes nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.

Nexium can cause serious (possibly fatal) stomach bleeding if taken with other medications. If you have any of the following symptoms, immediately contact your doctor.

• Stomach pain or acidity
• Vomiting
• Stomach pain, diarrhea, or vomiting
• Bloating
• Difficulty swallowing or breathing
• Hearing loss
• Heart attack or stroke (within the last 6 months)
• Blood cell problems (in your blood vessels, such as sickle cell anemia or multiple myeloma)
• Fainting

Serious side effects include (heart failure), a rare type of heart rhythm disorder called atrial fibrillation (a condition in which the heart beats more quickly than usual before it becomes too weak to pump)

Nexium and other medications may interact with:

• Some medicines (including certain antibiotics and antifungals)
• Certain recreational drugs
• Some antibiotics and antifungals
• Antibiotics like erythromycin, clarithromycin, itraconazole, ketoconazole, and rifampicin
• Some medications, including some over-the-counter and prescription medications, can affect how Nexium worksin vivo.

Before taking Nexium, tell your doctor or pharmacist if you are taking any other medications, including other proton pump inhibitors (e.g., esomeprazole), lansoprazole, or omeprazole. Nexium may interact with certain vaccines, such as typhoid vaccines. See your doctor for more details.

Nexium may cause serious (possibly fatal) stomach bleeding if taken with other medications

Tell your doctor or pharmacist if you are taking any of the following medications:

• Warfarin (low-blood-pressure medication like altegravir, porcine, human immunodeficiency virus (HIV) antigen-neumococcal) or clopidogrel (blood thinners like warfarin)
• Ciclosporin (for organ transplant patients)
• Mycophenolate (human epidermal growth sclerosis) or mycophenolate mofetil (for graft rejection)
• Proton pump inhibitors (e.g.

A 20-year-old woman presented to the emergency department with a history of frequent cough, persistent nausea, and a significant history of fever and chills. She was admitted because of severe abdominal pain, right lower quadrant pain, and right lower quadrant tenderness. She denied other medical conditions, including chronic pain, fatigue, and dyspnea. She denied recent or recent chemotherapy, radiotherapy, or surgery. She also denied any history of thyroid cancer, endocrine therapy, or medications, and her weight was within the normal range. A blood test for antinuclear antibodies (ANA) was positive for a substance known to be present in any of the blood products of alcohol and illicit drugs. Her serum thyroid hormone level was within the normal range, and serum albumin level was within the normal range. The patient was started on levothyroxine 300 mcg, and her fever improved, which was managed with antacids containing magnesium, calcium, and aluminum. The patient received intravenous baclofen 2 g, and her body weight increased, which was tapered off after three days of levothyroxine. At discharge, she showed improvement in her fatigue, right lower quadrant pain, and right lower quadrant tenderness. A visit to the emergency department was negative for thyroid stimulating hormone (TSH) levels. She was discharged home with the patient's blood test result.

Readers are encouraged to report negative side effects or side effects that are not well tolerated. If you experience any serious side effects, stop using this product and call your doctor immediately. Product information: NEXIUM® (Esomeprazole) (Nexium®) capsule.

What is NEXIUM (Esomeprazole) (Nexium®)?

NEXIUM (Esomeprazole) is a prescription medication that is used to treat conditions such as gastroesophageal reflux disease (GERD) and esophageal cancer. The brand name for NEXIUM is Esomeprazole. NEXIUM is manufactured by Merck & Co., Inc. NEXIUM (Esomeprazole) is used to treat gastroesophageal reflux disease (GERD), esophageal cancer, and other conditions that are caused by the acid in the stomach that occurs in eating disorders such as Zollinger-Ellison syndrome, chronic acid reflux disease (GERD), or gastroesophageal reflux disease (GERD-GERD) that is caused by medications such as Zithromax, Zomax, and Zolpidem. Esomeprazole is an older medication that was first approved by the Food and Drug Administration (FDA) in 1966. It is not currently available as an oral medication. NEXIUM is available as a capsule formulation. Esomeprazole is available as a liquid capsule. NEXIUM is available as a once-daily oral tablet. NEXIUM is sold in capsules. NEXIUM is a prescription medication. NEXIUM is used to treat reflux disease. NEXIUM is used to treat adults with chronic pain (acute GERD) and chronic cancer (breast cancer) that is caused by the following conditions: Zollinger-Ellison syndrome, chronic acid reflux disease (GERD), chronic cancer, and gastric cancer. NEXIUM is not indicated for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, or acute pain in children. NEXIUM is also not indicated for the treatment of acute pain in children.

What are the potential side effects of NEXIUM (Esomeprazole) (Nexium®)?

The most common side effects of NEXIUM (Esomeprazole) (Nexium®) are:

• Abdominal pain
• Headache
• Nausea
• Rash
• Vomiting
• Flatulence

What are the potential side effects of NEXIUM (Esomeprazole) (Nexium®) (Nexium®) capsules?

NEXIUM (Esomeprazole) (Nexium®) capsules contain esomeprazole, a proton pump inhibitor. Esomeprazole is also known as pantoprazole. Pantoprazole is a proton pump inhibitor used to treat stomach problems caused by stomach acids such as acid reflux disease and ulcers. Pantoprazole can cause diarrhea or nausea.

Possible Nexium Allergy Trial

This trial is an open-label, randomized, double-blind, placebo-controlled trial of Nexium, used as a single dose, to prevent heartburn in patients who have been experiencing heartburn at least once a year. The trial was conducted in 14 European, United States, and United Kingdom (UK) hospitals in which patients are inpatients. Patients were randomly assigned to receive one of two study treatments: Nexium 40 mg, placebo, or no treatment (n = 15). Patients were followed up for a year, at least 24 weeks after the trial ended. The primary outcome was the number of times patients experienced heartburn. The other outcome measures included a secondary outcome measure, the percentage of times patients experienced heartburn per year for each of the study treatments. A total of 9 patients (9 placebo and 9 Nexium, n = 9; 8 Nexium and 11 placebo) were enrolled. Patients received one of two treatment regimens. The patients received placebo or a combination of Nexium and placebo. In the control group, patients received placebo (placebo) or a combination of placebo and Nexium (n = 9). The patients in the treatment arm were also assessed for overall efficacy. The percentage of times patients experienced heartburn was significantly higher in the treatment group (3.5%) than in the control group (1.3%) (p < 0.0001). The percentage of times patients experienced heartburn per year for each of the study treatments was not significantly different from placebo (29.9 vs. 21.7, respectively, p = 0.19). There were no significant differences in heartburn incidence in patients treated with Nexium 40 mg and placebo in the control group (3.5% vs. 2.2%, respectively, p = 0.16) or in the study treatment group (3.5% vs. 2.2%, respectively, p = 0.16). The incidence of heartburn per year was significantly higher in the treatment group (4.2%) than in the control group (1.5%) (p < 0.0001). There was no significant difference in the incidence of heartburn per year for patients treated with Nexium 40 mg and placebo in the control group (0.9% vs. 0.5%, respectively, p = 0.45). There was no significant difference in the incidence of heartburn for patients treated with Nexium 40 mg and placebo in the study treatment group (0.5% vs. 0.6%, respectively, p = 0.39). There was no significant difference in the incidence of heartburn for patients treated with Nexium 40 mg and placebo in the study treatment group (0.9% vs. 0.7%, respectively, p = 0.39). The incidence of heartburn per year was significantly higher in the treatment group (0.8% vs. 0.3%, respectively, p = 0.04). The incidence of heartburn was not significantly different in the treatment group (0.3% vs. 0.1%, respectively, p = 0.65).

In the treatment group, 4 (2.3%) patients had severe heartburn (two or more) at baseline, two or more times a year, and one (1.9%) patient had a severe heartburn at baseline. Patients in the control group had a significantly lower percentage of times patients experienced heartburn (5.7% vs. 4.1%, respectively, p = 0.05) compared with the treatment group. Patients in the treatment group also experienced significantly more severe heartburn (two or more times a year) (p < 0.0001) at baseline. No serious adverse events were reported in the trial. In the control group, the incidence of heartburn per year was significantly higher than in the treatment group (2.3% vs. 1.4%, respectively, p = 0.02). The incidence of heartburn per year was significantly higher in the treatment group (4.2% vs. 3.5%, respectively, p = 0.03) than in the control group (1.6% vs. 0.7%, respectively, p = 0.33). There were no serious adverse events in the trial. The incidence of heartburn per year was significantly higher in the treatment group (3.5% vs. 2.2%, respectively, p = 0.09) than in the control group (1.3% vs. The incidence of heartburn was not significantly different in the treatment group (0.

Alternate Name:Pharmapure RX Esomep-EZS

Description:Nexium treats gastroesophageal reflux disease (GERD), esophagitis, and stomach ulcers. The generic version of Nexium is esomeprazole magnesium. For a supply of 30 oral tablets of Nexium Delayed-Release Capsules 40 mg is approximately $287. Take advantage of our LowerMyRx discount to receive a typical Nexium discount of up to 80% off of the retail price at participating pharmacies near you.

Dosage Form:Capsule Delayed Release

Administration Route:By mouth

Drug Class:Gastric Acid Secretion Inhibitor, Gastrointestinal Agent

Generic Available:Yes

Strength:20 MG

Warnings:Tell your doctor if you are pregnant or breastfeeding, or if you have kidney disease, liver disease, lupus, vitamin B12 deficiency, or osteoporosis. This medicine may cause the following problems: Kidney problems, including acute tubulointerstitial nephritisIncreased risk of broken bones in the hip, wrist, or spine (more likely if used several times per day or longer than 1 year)Serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and drug reaction with eosinophilia and systemic symptoms (DRESS)LupusFundic gland polyps (abnormal growth in the upper part of your stomach) This medicine can cause diarrhea. Call your doctor if the diarrhea becomes severe, does not stop, or is bloody. Do not take any medicine to stop diarrhea until you have talked to your doctor. Diarrhea can occur 2 months or more after you stop taking this medicine. Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments. Keep all medicine out of the reach of children. Never share your medicine with anyone. Stomach pain, nausea, vomiting, weight loss, bloody or black stools

Food Warnings:Do not use esomeprazole if you are also using medicines that contain rilpivirine., Some medicines can affect how esomeprazole works. Tell your doctor if you are using any of the following: Atazanavir, cilostazol, diazepam, digoxin, erlotinib, ketoconazole, methotrexate, mycophenolate mofetil, nelfinavir, rifampin, saquinavir, St John's wort, tacrolimus, voriconazoleBlood thinner (including clopidogrel or warfarin)Diuretic (water pill)Iron supplements, This medicine can cause diarrhea. Diarrhea can occur 2 months or more after you stop taking this medicine., Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results., Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments., Keep all medicine out of the reach of children.

In re ranitidine HCl/sodium-glutamate extended-release, 2.